Risky driving puts p-platers at high danger of crash |
|
|
|
Related media releases:
|
Research proves Tai Chi benefits for arthritis |
| Amanda Hall talks about Tai Chi and arthritis |
|
|
|
|
Related media releases:
|
China's first chronic disease center of excellence |
|
|
|
Related media releases:
|
Treatment of critically ill patients |
| Professor Simon Finfer talks about the results of the NICE-SUGAR study |
|
Related media releases:
|
Neglected disease research and development funding |
| Dr Mary Moran talks about the first ever global survey of investment into R&D for neglected diseases - G-FINDER |
|
| An online video of the G-FINDER launch event: See key international commentators in an interactive forum discussing the year one results of the G-FINDER report, hosted by Andrew Jack of the Financial Times.
|
|
Related media releases:
|
Back pain recurrence in Australia |
| Professor Chris Maher talks about the amount of back pain suffered in Australia |
| Professor Chris Maher talks about the study findings on the recurrence of back pain |
| Professor Chris Maher talks about what clinicians can do to help patients reduce the risks of back pain |
| Professor Chris Maher talks about what patients can do to avoid back pain (Part 1) |
| Professor Chris Maher talks about what patients can do to avoid back pain (Part 2) |
| Professor Chris Maher talks about future research on back pain |
|
Related media release: Back pain still an issue for over five million australians: are we treating it right? |
Type 2 diabetes |
| Professor Stephen MacMahon, ADVANCE Co-principal Investigator, The George Institute for International Health explains what the results of the ADVANCE trial contribute to the treatment of Type 2 diabetes |
| Associate Professor Anushka Patel, ADVANCE Study Lead Investigator, The George Institute for International Health explains what the results of the ADVANCE trial will mean to patients |
| Professor John Chalmers, ADVANCE Co-principal Investigator, The George Institute for International Health talks about the burden of Type 2 diabetes |
| Professor Mark Cooper, Head of the Diabetes & Metabolism Division, Baker Institute, Melbourne and ADVANCE Management Committee Member explains what the ADVANCE results contribute to our understanding of Type 2 diabetes |
| David Jayne, Diabetes Patient & ADVANCE study participant talks about his diabetes and participation in the ADVANCE study |
|
Related media release: ADVANCE trial shows combined treatments provide 33% reduction of serious kidney complications in type 2 diabetes |